BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23156272)

  • 1. [Genetic diagnosis of the endometrial cancer].
    Kimura T; Fujita M; Kobayashi E; Ueda Y; Yoshino K; Enomoto T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():367-71. PubMed ID: 23156272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topics on gene abnormality in endometrial cancer].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():259-63. PubMed ID: 15535247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular mechanisms in endometrial carcinoma].
    Nakao Y; Iwasaka T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():248-53. PubMed ID: 15535245
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetic abnormalities in the pathogenesis of ovarian cancer].
    Yoshino K; Ueda Y; Kimura T; Kobayashi E; Fujita M; Enomoto T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():480-7. PubMed ID: 23156294
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and endometrial cancer.
    Lalloo F; Evans G
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):355-63. PubMed ID: 11476558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of endometrial carcinoma.
    Matias-Guiu X; Prat J
    Histopathology; 2013 Jan; 62(1):111-23. PubMed ID: 23240673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
    Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
    Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
    Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the molecular genetics of endometrial cancer (Review).
    Esteller M; Xercavins J; Reventos J
    Oncol Rep; 1999; 6(6):1377-82. PubMed ID: 10523715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
    Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
    Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic abnormalities in endometrial cancer].
    Takeshima N; Hirai Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
    [No Abstract]   [Full Text] [Related]  

  • 15. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
    Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
    Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
    Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
    Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic diagnosis of endometrial cancer].
    Kanaya T; Kyo S; Maida Y; Inoue M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():295-8. PubMed ID: 15535254
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability and somatic mutations in endometrial carcinomas.
    Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N
    Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathology of ovarian cancer.
    Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
    Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.